BioXcel Therapeutics, Inc. (BTAI)
1.13
-0.01
(-0.88%)
USD |
NASDAQ |
May 22, 16:00
1.14
+0.01
(+0.88%)
After-Hours: 20:00
BioXcel Therapeutics Total Assets (Quarterly) : 34.02M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Verastem, Inc. | 227.81M |
| Quince Therapeutics, Inc. | 26.62M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| Amgen, Inc. | 92.50B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 139.57M |
| Shareholders Equity (Quarterly) | -105.54M |
| Debt to Equity Ratio | -0.9502 |
| Current Ratio | 0.6166 |
| Net Debt Paydown Yield | 1.47% |